The new recombinant shingles vaccine, ‘Shingrix,’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study.
Shingrix (herpes zoster vaccine (recombinant, adjuvanted)). (Credit: Whispyhistory / CC BY-SA 4.0)
